

EDUCATION AND TRAINING
Postdoctoral Training, Biochemistry, University of Pennsylvania,
Philadelphia, PA
Ph.D., Bioengineering, University of Washington, Seattle, WA
|
|
Ian Sweet, Ph.D.
Research Assistant Professor
Division of Metabolism, Endocrinology and Nutrition
Director, Islet Core, UW DERC
Affiliate Investigator, Benaroya Research Institute
OFFICE ADDRESS
University of Washington School of Medicine
1959 NE Pacific
UW Mailbox 357710
Seattle, WA 98195
CURRENT RESEARCH INTERESTS
Understanding the dual role of mitochondrial energy production in
mediating nutrient stimulated insulin secretion system and in
maintaining viability of pancreatic beta cells. Methods
have been developed to continuously assess oxygen consumption,
cytochrome redox state, calcium and NAD(P)H levels in isolated islets
concomitantly with insulin secretion. These
techniques are being used to examine the bioenergetics of nutrient
induced insulin secretion, the mechanisms of calcium mediated insulin
secretion, real time kinetics of apoptosis and necrosis, the
contribution of compromised islet function to the progression of type
2 diabetes and the acute and chronic effects of GLP-1 on islet
function. Specific
applications have focused on assessing viability of human islets for
transplantation; optimization of encapsulation techniques for
transplanting immunoisolated islets; improving the response of islet
function to hypoxia (a major issue in the preparation and
transplantation of islets); and development of PET-based imaging
methods to assess beta-cell mass in vivo. Some
of the methods we have developed are available as Core services
through the DERC Islet Core (http://depts.washington.edu/diabetes/biomedcore/ifac.index.html).
REPRESENTATIVE PUBLICATIONS
Sweet IR, Najafi H, Li G, Berner DK, Matschinsky
FM: Effect of a
glucokinase inhibitor on energy production and insulin release in
pancreatic islets. Am J Physiol 271:E606-E625, 1996.
Sweet IR, Cook DL, Wiseman RW, Greenbaum CJ, Lernmark A, Matsumoto S,
Teague JC, Krohn KA: Dynamic
perifusion to maintain and assess isolated pancreatic islets. Diabetes
Tech Ther 4:67-76, 2002.
Sweet IR, Khalil G, Wallen AR, Steedman M, Schenkman KA, Reems JA,
Kahn SE, Callis JB: Continuous
measurement of oxygen consumption by pancreatic islets. Diabetes Tech
Ther 4:661-672, 2002.
Sweet IR, Cook DL, DeJulio E, Wallen AR, Khalil G, Callis JB, Reems
JA: Regulation of ATP/ADP
in pancreatic islets. Diabetes 53:401-409, 2004.
Sweet IR, Cook DL, Lernmark A, Greenbaum CJ,
Stekhova S, Wallen A, Krohn KA: Screening
for beta cell imaging agents. Biochem
Biophys Res Comm 314:976-983, 2004.
Sweet IR, Cook DL, Lernmark A, Greenbaum CJ, Krohn KA:
Non-invasive imaging of beta cell mass:
A quantitative analysis. Diabetes
Tech Ther 6:652-659, 2004.
Hampe CS, Wallen AR, Binder K, Schlosser M, Ziegler M, Sweet IR:
Quantitative evaluation of a monoclonal antibodies and its
fragment as potential beta markers for pancreatic beta cell mass.
Exp Clinical Endo Diabetes 113:381-387, 2005.
Sweet IR, Gilbert M, Sabek O, Fraga DW, Gaber AO, Reems JA:
Glucose stimulation of cytochrome c reduction and oxygen
consumption as assessment of human islet quality.
Transplantation 80:1003-1011, 2005.
Sweet IR, Gilbert M: Contribution of calcium influx in mediating
glucose-stimulated oxygen consumption in pancreatic islets.
Diabetes 55:3509-3519, 2006.
Sweet IR, Gilbert M, Scott S, Todorov I, Jensen R, Nair I, Al-Abdullah
I, Rawson J, Mullen Y, Kandeel F, Ferreri K:
Glucose-stimulated increment in oxygen consumption rate as a
standardized test of human islet quality.
Amer J Trans 8:183-192, 2008.
|